Manuscripts
Showing 1530 manuscripts.
Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action
Citation
Martina Penazzato, Shahin Lockman, Angela Colbers, Françoise Renaud, Alexandra Calmy, Polly Clayden, Marissa Vicari, Imelda C Mahaka, Jennifer M Zech, Cadi Irvine, Elaine J Abrams, Participants of the WHO-IMPAACT Workshop “Approaches to Enhance and Accelerate Study of New Drugs for HIV and Associated Infections in Pregnant Women”. Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action. Journal of the International AIDS Society. 2022. 25: e25912. PMID: 35851834
Year
Journal
Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial
Citation
Anne-Marie Demers, Soyeon Kim, Sara McCallum, Kathleen Eisenach, Michael Hughes, Linda Naini , Alberto Mendoza-Ticona , Neeta Pradhan, Kim Narunsky, Selvamuthu Poongulali , Sharlaa Badal-Faesen, Caryn Upton, Elizabeth Smith , N Sarita Shah , Gavin Churchyard, Amita Gupta, Anneke Hesseling, Susan Swindells , ACTG A5300/IMPAACT I2003 PHOENIx Feasibility study team. Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial. BMC Infectious Diseases. 2021. 21: 205. PMID: 33627075
Year
Journal
Study
Caregiver willingness to give TPT to children living with drug-resistant TB patients
Citation
V Rouzier, M Murrill, S Kim, L Naini, J Shenje, E Mitchell, M Raesi, M Lourens, A Mendoza, F Conradie, N Suryavanshi, M Hughes, S Shah, G Churchyard, S Swindells, A Hesseling, A Gupta. Caregiver willingness to give TPT to children living with drug-resistant TB patients. International Journal of Tuberculosis and Lung Disease. 2022. 26: 949-955. PMID: 36163664
Year
Journal
Study
The cascade of care for household contacts of people with drug-resistant TB
Citation
Isabella Gomes, Tushar Garg, Gavin Churchyard, Amita Gupta, Anneke C Hesseling, Susan Swindells, Wilfred Gurupira, Bruno Martel, Lungile Mbata, Sandesh Patil, Cynthia Riviere, Mariecef Tonquin, David Dowdy, Hojoon Sohn. The cascade of care for household contacts of people with drug-resistant TB. International Journal of Tuberculosis and Lung Disease. 2023. 27: 154-156. PMID: 36853100
Year
Journal
Study
Resistance to Mycobacterium tuberculosis Infection Among Household Contacts: A Multinational Study
Citation
Davit Baliashvili, Neel R Gandhi, Soyeon Kim, Michael Hughes, Vidya Mave, Alberto Mendoza-Ticona, Pedro Gonzales, Kim Narunsky, Poongulali Selvamuthu, Sharlaa Badal-Faesen, Caryn Upton, Linda Naini, Elizabeth Smith, Amita Gupta, Gavin Churchyard, Susan Swindells, Anneke Hesseling, N Sarita Shah. Resistance to Mycobacterium tuberculosis Infection Among Household Contacts: A Multinational Study. Clinical Infectious Diseases. 2021. 73: 1037-1045. PMID: 33772550
Year
Journal
Study
Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household
Citation
Soyeon Kim, Anneke C Hesseling, Xingye Wu, Michael D Hughes, N Sarita Shah, Sanjay Gaikwad, Nishi Kumarasamy, Erika Mitchell, Mey Leon, Pedro Gonzales, Sharlaa Badal-Faesen, Madeleine Lourens, Sandy Nerette, Justin Shenje, Petra de Koker, Supalert Nedsuwan, Lerato Mohapi, Unoda A Chakalisa, Rosie Mngqbisa, Rodrigo Otávio da Silva Escada, Samuel Ouma, Barbara Heckman, Linda Naini, Amita Gupta, Susan Swindells, Gavin Churchyard, ACTG A5300/IMPAACT 2003 PHOENIx Feasibility Study Team. Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household. PLoS One. 2023. 18: e0283290. PMID: 36930628
Year
Journal
Study
Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial
Citation
Lameck Chinula, Lauren Ziemba, Sean Brummel, Katie McCarthy, Anne Coletti, Chelsea Krotje, Benjamin Johnston, Kevin Knowles, Sikhulile Moyo, Lynda Stranix-Chibanda, Risa Hoffman, Paul E Sax, Jeffrey Stringer, Nahida Chakhtoura, Patrick Jean-Philippe, Violet Korutaro, Haseena Cassim, Lee Fairlie, Gaerolwe Masheto, Ceejay Boyce, Lisa M Frenkel, K Rivet Amico, Lynette Purdue, Roger Shapiro, Blandina Theophil Mmbaga, Faeezah Patel, Jean van Wyk, James F Rooney, Judith S Currier, Shahin Lockman, IMPAACT 2010/VESTED Study Team and Investigators. Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet HIV. 2023. S2352-3018: 00061-9. PMID: 37167996
Year
Journal
Study
A Per-Protocol Analysis using Inverse Probability of Censoring Weights in a Randomized Trial of Initial PI versus NNRTI Regimens in Children
Citation
Dwight E. Yin, Stephen R. Cole, Christina Ludema, M. Alan Brookhart, Carol E. Golin, William C. Miller, Ross E. McKinney. A Per-Protocol Analysis using Inverse Probability of Censoring Weights in a Randomized Trial of Initial PI versus NNRTI Regimens in Children. American Journal Of Epidemiology. 2023. 192: 916-928. PMID: 36896583
Year
Journal
Bone and renal health in infants with or without breastmilk exposure to tenofovir-based maternal antiretroviral treatment in the PROMISE randomized trial
Citation
Tichaona Vhembo, Kristin Baltrusaitis, Camlin Tierney, Maxensia Owor, Sufia Dadabhai, Avy Violari, Gerhard Theron, Dhayendre Moodley, Cynthia Mukwasi-Kahari, Kathleen George, John Shepherd, George K. Siberry, Renee Browning, Mary Glenn Fowler, Lynda Stranix-Chibanda, IMPAACT P1084s Study Team. Bone and renal health in infants with or without breastmilk exposure to tenofovir-based maternal antiretroviral treatment in the PROMISE randomized trial. Journal of AIDS. 2023. PMID: 37199427
Year
Journal
Study
Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis among known HIV-exposed infants in resource-limited settings
Citation
Caitlin M. Dugdale, Ogochukwu Ufio, Christopher Alba, Sallie R. Permar, Lynda Stranix-Chibanda, Coleen K. Cunningham, Genevieve G. Fouda, Landon Myer, Milton C. Weinstein, Valériane Leroy, Elizabeth J. McFarland, Kenneth A. Freedberg, Andrea L. Ciaranello. Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis among known HIV-exposed infants in resource-limited settings. Lancet. 2023. PMID: 36604316